Lenox Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$202K Sell
647
-34
-5% -$8.75K 0.03% 112
2021
Q4
$188K Buy
681
+56
+9% +$14.2K 0.02% 117
2021
Q3
$144K Buy
625
+7
+1% +$1.73K 0.02% 130
2021
Q2
$142K Buy
618
+562
+1,004% +$113K 0.02% 131
2021
Q1
$10K Buy
+56
New +$11K ﹤0.01% 421
2020
Q3
Sell
-80
Closed -$13K 617
2020
Q2
$13K Buy
+80
New +$12.3K ﹤0.01% 345
2018
Q3
Sell
-694
Closed -$59K 475
2018
Q2
$59K Buy
694
+540
+351% +$44.4K 0.01% 126
2018
Q1
$12K Buy
154
+112
+267% +$9.02K ﹤0.01% 338
2017
Q4
$4K Buy
42
+38
+950% +$3.23K ﹤0.01% 242
2017
Q3
$0 Buy
+4
New +$328 ﹤0.01% 262
2016
Q1
Sell
-61
Closed -$5K 341
2015
Q4
$5K Sell
61
-69
-53% -$5.73K ﹤0.01% 224
2015
Q3
$11K Hold
130
﹤0.01% 176
2015
Q2
$11K Hold
130
﹤0.01% 132
2015
Q1
$9K Hold
130
﹤0.01% 169
2014
Q4
$9K Sell
130
-104
-44% -$7.02K ﹤0.01% 176
2014
Q3
$15K Hold
234
0.01% 149
2014
Q2
$15K Buy
234
+130
+125% +$7.76K 0.01% 128
2014
Q1
$6K Sell
104
-75
-42% -$4.19K ﹤0.01% 157
2013
Q4
$9K Buy
179
+75
+72% +$3.76K 0.01% 177
2013
Q3
$5K Sell
104
-450
-81% -$23.6K ﹤0.01% 164
2013
Q2
$27K Buy
+554
New +$30.1K 0.03% 54

Other funds holding LLY

Lenox Wealth Advisors's LLY Position: Q1 2022 in Review

Lenox Wealth Advisors reduced its Eli Lilly (LLY) stake by 5% in Q1 2022, selling an estimated $8.75K and leaving 647 shares worth $202K. The position accounts for 0.03% of the portfolio, ranked #112.

Lenox Wealth Advisors first reported a position in LLY in Q2 2013 and has held it in 21 quarters since. 2,346 funds tracked by Wall St. Rank hold LLY as of Q1 2022.

  • Lenox Wealth Advisors held 647 shares of Eli Lilly worth $202K as of Q1 2022.
  • Lenox Wealth Advisors sold 34 Eli Lilly shares in Q1 2022, an estimated $8.75K.
  • Eli Lilly made up 0.03% of Lenox Wealth Advisors's portfolio in Q1 2022, its #112 holding.
  • Lenox Wealth Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 21 quarters since.
  • 2,346 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2022.

Based on Lenox Wealth Advisors's 13F filing for Q1 2022, filed 14 Apr 2022.